哈三联(002900) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥230,179,061.88, a decrease of 20.30% compared to ¥288,795,847.25 in the same period last year[8] - Net profit attributable to shareholders was ¥563,299,946.56, representing a significant increase of 1,660.87% from ¥31,989,844.02 year-on-year[8] - The net profit after deducting non-recurring gains and losses was -¥13,367,118.30, a decrease of 1,957.41% compared to ¥719,665.24 in the previous year[8] - The basic earnings per share rose to ¥1.78, up 1,680.00% from ¥0.10 in the same period last year[8] - The company reported a significant increase in undistributed profits, rising to CNY 876,849,656.40 from CNY 341,231,297.92, an increase of approximately 157%[39] - The company expects a significant increase in net profit for the year, projecting a net profit of CNY 55,000 million, which is a 1,856.54% increase compared to the previous year[27] - Basic earnings per share are projected to be CNY 1.74, reflecting an increase of 1,859.68% compared to the previous year[27] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,029,396,416.51, an increase of 22.02% from ¥2,482,760,796.58 at the end of the previous year[8] - The total owner's equity increased to CNY 2,354,821,384.90 from CNY 1,791,577,744.66, marking an increase of about 31.4%[39] - Total liabilities decreased to CNY 674,575,031.61 from CNY 691,183,051.92, a reduction of approximately 2.4%[38] - The total assets reached CNY 3,129,172,534.87, compared to CNY 2,582,157,257.32 in the previous period, reflecting growth in the company's asset base[45] - Total liabilities decreased to CNY 561,592,080.70 from CNY 586,699,473.07 in the previous period[45] Cash Flow - The net cash flow from operating activities was -¥53,689,535.89, an improvement of 23.24% compared to -¥69,947,180.42 in the previous year[8] - The cash flow from operating activities showed a net outflow of CNY -53,689,535.89, an improvement from CNY -69,947,180.42 in the same period last year[54] - The cash inflow from investment activities was 20,183,375.58 CNY, compared to 367,625,156.95 CNY in the previous year, indicating a decrease in investment activity[58] - The net cash flow from investment activities was -336,969,016.27 CNY, indicating a significant outflow compared to the previous year's outflow of -8,908,778.33 CNY[58] - The cash flow from financing activities showed a net inflow of CNY 56,701,847.86, compared to CNY 9,814,639.46 in the previous year, reflecting a positive trend[55] Investments - The company reported non-recurring gains of ¥576,667,064.86, primarily due to the investment in 100% equity of Harbin Beixing Pharmaceutical Co., Ltd.[9] - Investment income surged by 8582.81% to ¥568,753,081.17, resulting from a 100% equity investment in Harbin Beixing Pharmaceutical Co., Ltd.[17] - The company made an investment in Harbin Fuyijia Technology Co., Ltd., acquiring 5% equity, resulting in an investment income of ¥56,649,000[19] - The company has committed a total investment of CNY 90,011.90 million for various projects, with a cumulative investment of CNY 28,980.84 million, representing 32.2% of the total commitment[24] Operational Changes - The marketing strategy is being adjusted to enhance the sales service system and improve market control capabilities[25] - The company adjusted its financial statements in accordance with the new leasing standards effective from January 1, 2021[63] - The company reported a long-term receivable of CNY 205,234,963.50, unchanged from the previous period[65] Shareholder Information - The total number of shareholders at the end of the reporting period was 37,766, with the top shareholder holding 39.07% of the shares[12]